Avadel Pharmaceuticals PLC (AVDL)
18.59
-0.23
(-1.22%)
USD |
NASDAQ |
May 06, 16:00
18.60
+0.02
(+0.08%)
After-Hours: 20:00
Avadel Pharmaceuticals Cash from Investing (TTM): -50.09M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -50.09M |
September 30, 2023 | -55.15M |
June 30, 2023 | -62.44M |
March 31, 2023 | 42.51M |
December 31, 2022 | 79.70M |
September 30, 2022 | 72.14M |
June 30, 2022 | 81.91M |
March 31, 2022 | 87.99M |
December 31, 2021 | 56.93M |
September 30, 2021 | 48.85M |
June 30, 2021 | 27.26M |
March 31, 2021 | -71.76M |
December 31, 2020 | -69.72M |
September 30, 2020 | -71.79M |
June 30, 2020 | -59.28M |
March 31, 2020 | 30.56M |
December 31, 2019 | 38.72M |
September 30, 2019 | 49.76M |
June 30, 2019 | 72.57M |
March 31, 2019 | 65.15M |
December 31, 2018 | -36.98M |
September 30, 2018 | -53.72M |
June 30, 2018 | -78.67M |
March 31, 2018 | -64.45M |
December 31, 2017 | -15.70M |
Date | Value |
---|---|
September 30, 2017 | -1.709M |
June 30, 2017 | -2.76M |
March 31, 2017 | -27.63M |
December 31, 2016 | -36.63M |
September 30, 2016 | -58.69M |
June 30, 2016 | -71.29M |
March 31, 2016 | -49.29M |
December 31, 2015 | -31.73M |
September 30, 2015 | -9.149M |
June 30, 2015 | -29.51M |
March 31, 2015 | -38.72M |
December 31, 2014 | -43.08M |
September 30, 2014 | -55.24M |
June 30, 2014 | -22.60M |
March 31, 2014 | -26.34M |
December 31, 2013 | 6.045M |
September 30, 2013 | 10.18M |
June 30, 2013 | 13.69M |
March 31, 2013 | 15.40M |
December 31, 2012 | 15.45M |
September 30, 2012 | 9.946M |
June 30, 2012 | 3.757M |
March 31, 2012 | 0.884M |
December 31, 2011 | -0.351M |
September 30, 2011 | 3.446M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-71.79M
Minimum
Sep 2020
87.99M
Maximum
Mar 2022
13.09M
Average
38.72M
Median
Dec 2019
Cash from Investing (TTM) Benchmarks
Trinity Biotech PLC | 24.76M |
Medtronic PLC | -2.145B |
Akari Therapeutics PLC | -- |
Biophytis SA | 0.3879M |
TC BioPharm (Holdings) PLC | -0.2614M |